Daniel R. Karlin, MD, MA
Chief Medical Officer, Recovery Delivered
Dr. Daniel R. Karlin, MD, MA, is a psychiatrist, addiction medicine specialist and medical informatician. He is Recovery Delivered's Chief Medical Officer. He built the clinical protocols our providers use, and he reviews Recovery Delivered's published health content. His work sits where health and technology meet: psychiatric drug development, new ways to measure symptoms, and data-driven methods for clinical research and clinical care.
He brings that training, and his experience treating addiction with medication, to every page he reviews. The goal is simple: information patients can rely on, that is accurate, current and based on evidence.
What he reviews
Dr. Karlin reads each version of these pages before his name appears on them:
- Every article on the Addiction Blog, including the Suboxone price guide
- Opioid use disorder care: Online Suboxone Doctors, Generic Suboxone, medication-assisted treatment, medication delivery and addiction medications
- Weight loss: tirzepatide, semaglutide and prescription weight loss
- Alcohol use disorder: medication for alcohol use disorder, the naltrexone guide, Antabuse, Campral and the Sinclair Method
- Drug testing
How we write, source and correct these pages is set out in our editorial policy.
Training
- BA, Neuroscience and Behavior, Columbia University
- MA, Clinical Informatics and Cognition (Biomedical Informatics), Columbia University
- MD, University of Colorado School of Medicine
- Psychiatry residency, Tufts Medical Center, where he was named Executive Chief Resident after two years
Research
Dr. Karlin's research covers psychiatry, addiction medicine, psychedelic medicine, medical informatics and digital measures of health. His work has been cited 1,478 times, with an h-index of 19, on Google Scholar as of October 16, 2026. PubMed lists 21 of his papers.
| Paper | Journal | Year |
|---|---|---|
| Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Trial | JAMA | 2025 |
| Implementing precision methods in personalizing psychological therapies: Barriers and possible ways forward | Behaviour Research and Therapy | 2024 |
| The digital redesign of mental health: leveraging connected digital technologies for agency-driven patient-focused care | British Journal of Psychiatry | 2023 |
| Digital Medicine: A Primer on Measurement | Digital Biomarkers | 2019 |